Close Menu
Invest Intellect
    Facebook X (Twitter) Instagram
    Invest Intellect
    Facebook X (Twitter) Instagram Pinterest
    • Home
    • Commodities
    • Cryptocurrency
    • Fintech
    • Investments
    • Precious Metal
    • Property
    • Stock Market
    Invest Intellect
    Home»Stock Market»Here’s Why We’re Wary Of Buying GSK’s (LON:GSK) For Its Upcoming Dividend
    Stock Market

    Here’s Why We’re Wary Of Buying GSK’s (LON:GSK) For Its Upcoming Dividend

    February 14, 20254 Mins Read


    Some investors rely on dividends for growing their wealth, and if you’re one of those dividend sleuths, you might be intrigued to know that GSK plc (LON:GSK) is about to go ex-dividend in just four days. The ex-dividend date is one business day before the record date, which is the cut-off date for shareholders to be present on the company’s books to be eligible for a dividend payment. The ex-dividend date is an important date to be aware of as any purchase of the stock made on or after this date might mean a late settlement that doesn’t show on the record date. Accordingly, GSK investors that purchase the stock on or after the 20th of February will not receive the dividend, which will be paid on the 10th of April.

    The company’s next dividend payment will be UK£0.16 per share. Last year, in total, the company distributed UK£0.61 to shareholders. Based on the last year’s worth of payments, GSK stock has a trailing yield of around 4.3% on the current share price of UK£14.35. Dividends are a major contributor to investment returns for long term holders, but only if the dividend continues to be paid. So we need to check whether the dividend payments are covered, and if earnings are growing.

    See our latest analysis for GSK

    Dividends are typically paid out of company income, so if a company pays out more than it earned, its dividend is usually at a higher risk of being cut. Last year GSK paid out 97% of its profits as dividends to shareholders, suggesting the dividend is not well covered by earnings. That said, even highly profitable companies sometimes might not generate enough cash to pay the dividend, which is why we should always check if the dividend is covered by cash flow. Dividends consumed 66% of the company’s free cash flow last year, which is within a normal range for most dividend-paying organisations.

    It’s good to see that while GSK’s dividends were not well covered by profits, at least they are affordable from a cash perspective. Still, if this were to happen repeatedly, we’d be concerned about whether the dividend is sustainable in a downturn.

    Click here to see the company’s payout ratio, plus analyst estimates of its future dividends.

    historic-dividend
    LSE:GSK Historic Dividend February 15th 2025

    Businesses with shrinking earnings are tricky from a dividend perspective. If business enters a downturn and the dividend is cut, the company could see its value fall precipitously. Readers will understand then, why we’re concerned to see GSK’s earnings per share have dropped 12% a year over the past five years. When earnings per share fall, the maximum amount of dividends that can be paid also falls.

    Many investors will assess a company’s dividend performance by evaluating how much the dividend payments have changed over time. GSK has seen its dividend decline 4.8% per annum on average over the past 10 years, which is not great to see. It’s never nice to see earnings and dividends falling, but at least management has cut the dividend rather than potentially risk the company’s health in an attempt to maintain it.

    Is GSK an attractive dividend stock, or better left on the shelf? It’s never fun to see a company’s earnings per share in retreat. Worse, GSK’s paying out a majority of its earnings and more than half its free cash flow. Positive cash flows are good news but it’s not a good combination. Overall it doesn’t look like the most suitable dividend stock for a long-term buy and hold investor.

    Having said that, if you’re looking at this stock without much concern for the dividend, you should still be familiar of the risks involved with GSK. For example, we’ve found 4 warning signs for GSK that we recommend you consider before investing in the business.

    If you’re in the market for strong dividend payers, we recommend checking our selection of top dividend stocks.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.



    Source link

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    ThingX Technology Launches Nuna Pendant This 2025Q3: The World’s First AI Emotion-Tracking Pendant

    Stock Market

    The Motley Fool: Invest in diversified dividends

    Stock Market

    How technology in the FCS might affect a team’s preparation and in-game adjustments

    Stock Market

    If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I’d Go With These 11 Dividend Stocks

    Stock Market

    The agricultural renaissance: Modern farming, technology, and new crops

    Stock Market

    A beginner’s guide to AI for Boomers, from technology writer Jonathan Margolis

    Stock Market
    Leave A Reply Cancel Reply

    Top Picks
    Commodities

    Carving a Future in Agribusiness

    Commodities

    Ambos Energy récolte 10 M€ pour détenir et exploiter de grosses batteries

    Commodities

    Soventix s’engage sur le projet solaire de 222 MWp pour alimenter la mine de Kamoa-Kakula

    Editors Picks

    Do energy drinks cause heart issues?

    July 19, 2024

    AI investments see more than twofold rise in 2025 in India

    April 26, 2025

    The illusion of stability – Opinion News

    April 18, 2025

    BC woman loses $15K in cryptocurrency scam, threatened with violence

    February 26, 2025
    What's Hot

    Trump set to freenlight crypto in 401(k)s, Bitcoin rallies on retirement reform push

    August 7, 2025

    Gold Monthly: US rate cut drives gold rally | articles

    October 11, 2024

    US Dividend Stocks To Consider For Your Portfolio

    October 24, 2024
    Our Picks

    Tech rally, bond yields, metal commodities: Market Takeaways

    August 16, 2024

    Private equity investments in Indian real estate jump 38% to $2.4 bn in H1 2025

    July 10, 2025

    Will digital currencies wane or flourish as banks adopt ISO 20022?

    November 11, 2022
    Weekly Top

    Gujarat emerges as India’s copper hub, amid soaring demand from sunrise sectors – Industry News

    August 24, 2025

    Four quick and easy DIY tricks to boost your property value by nearly £30k

    August 24, 2025

    BRAC EPL Investments partners with Paramount Solar to boost renewable energy expansion

    August 24, 2025
    Editor's Pick

    Crypto Gustodian Copper lance une plate-forme de prêt d’agence

    February 13, 2025

    Ferrari Expands Cryptocurrency Payment To Europe After US Success

    July 24, 2024

    7 Easiest Countries for Americans to Buy a House Abroad

    July 7, 2024
    © 2025 Invest Intellect
    • Contact us
    • Privacy Policy
    • Terms and Conditions

    Type above and press Enter to search. Press Esc to cancel.